MENS
Jyong Biotech Ltd. Ordinary Shares NASDAQ$2.11
Mkt Cap $160.4M
52w Low $1.43
1.0% of range
52w High $67.00
50d MA $2.25
200d MA $23.30
P/E (TTM)
-56.7x
EV/EBITDA
-422.0x
P/B
—
Debt/Equity
-0.5x
ROE
—
P/FCF
-212.1x
RSI (14)
—
ATR (14)
—
Beta
8.47
50d MA
$2.25
200d MA
$23.30
Avg Volume
254.2K
About
Jyong Biotech Ltd. is a Taiwan-based biotech firm focused on developing and commercializing plant-derived drugs targeting urinary system diseases. The company operates through its subsidiaries—Health Ever Bio-Tech, Genvace, and others—working on drug candidates like MCS‑2 (for BPH) currently in Phase III, PCP (for prostate cancer) in Phase II, and IC in pre-clinical stages
Data updated apr 26, 2026 11:51am
· Source: massive.com